Pliant Therapeutics, Inc. is a cutting-edge biopharmaceutical company based in South San Francisco, CA, dedicated to revolutionizing the treatment of fibrotic diseases. With a focus on targeted integrin therapies, their team of experienced experts is committed to discovering breakthrough therapies that offer hope to patients suffering from fibrosis. By understanding the molecular drivers of fibrotic diseases, Pliant aims to develop safer and more effective treatments, paving the way for a brighter future for those affected by these conditions.
With a broad pipeline that includes two clinical stage programs, Pliant Therapeutics is at the forefront of tissue-specific therapies. Their pioneering approach has the potential to significantly advance the treatment of fibrosis, and they recognize the importance of collaboration with patients on this journey. By harnessing the power of science and innovation, Pliant Therapeutics is breaking new ground in the field of fibrosis treatment, offering hope and improved quality of life to individuals affected by these debilitating diseases.
Generated from the website